Laurus Labs has successfully completed the United States Food and Drug Administration (USFDA) inspection for its API facility of the Unit 2 without any Form 483 observations. The formulations unit in the same facility has however received Establishment Inspection Report (EIR) on May 18, 2017. The Unit-2 that manufactures active pharmaceutical ingredients and finished dosage formulations is located in APSEZ at Achutapuram, Vizag.
Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.
